[1]
Nour-Eddine Ziraoui, Sofia Rossi, and D. Volkov, “Clinical Evaluation of a Time-Sequential Biphasic NMN–Resveratrol–Quercetin–Piperine NAD+ Supplement Targeting SIRT1 (BCLC™)”, FSD, vol. 6, no. 4, pp. 1–9, Apr. 2026, doi: 10.54691/7pt02z87.